Strategic question
Which APAC markets should we prioritise for Digital Health investment, and where is our franchise readiness strongest?
How Galen Growth helped
From market signal to decision-ready evidence
Applying our PlayBook methodology on HealthTech Alpha, we evaluated four APAC markets against user cohorts, therapeutic mix, bio-pharma partnership activity and venture depth, and profiled 10 ventures in detail to validate strategic fit.
Outcomes
Produced a franchise-level view of where Digital Health readiness was real, where it was nascent, and where investment would compound.
Decision enabled: Enabled franchise leadership to prioritise resource allocation and scouting effort across APAC markets.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Tracking Competitor Moves to Support Global Franchise Strategy
How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?
Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap
Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?
Benchmarking Global Competitor Partnerships to Prioritise Digital Health Strategy
Where are competitors investing and partnering in Digital Health, and what should that mean for our own portfolio strategy?